Prelabor Rupture of Membranes, Previous; Cesarean Section, Cicatricial, Complicating Pregnancy or Childbirth, Affecting Fetus or Newborn
Conditions
Keywords
Induction of labor, Previous cesarean delivery, Trial of labor after cesarean, Prelabor rupture of membranes, balloon induction
Brief summary
A prospective randomized controlled trial to evaluate the safety and efficacy of labor induction with a double balloon catheter (Atad Ripener Device) in women desiring TOLAC (trial of labor after cesarean) with PROM (pre labor rupture of membranes).
Interventions
DEVICEDouble Balloon catheter for induction of labor
With the patient in lithotomy position or lying supine in bed, a speculum is inserted to visualise the cervix. The device is inserted into the cervix using long forceps until both balloons enter the cervical canal. Then, the uterine balloon is inflated with 20 ml of saline (by means of a 20 ml syringe). The device is then pulled out until stopped by the uterine balloon covering the internal cervical os. At this point the cervico-vaginal balloon located at the external os is inflated with 20 ml of saline and the speculum is removed. Then both balloons are additionally inflated with alternate increments of 20 ml normal saline to a total volume of 80 ml in each balloon. The device is loosely taped to the patient's inner thigh.
Sponsors
Soroka University Medical Center
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Intervention model description
200 pregnant women with one previous cesarean section and PROM along with an unfavourable cervix (Bishop Score ≤ 6) are expected to be entered into the study. All eligible women will be presented with the study protocol by a study coordinator.The following screening medical procedures will be completed: Medical and gynecological history, physical and vaginal speculum examination, Ultrasonography and a non-stress test (NST). For eligible patients, and following an informed consent, group randomization will take place: GROUP 1: Expectant management (standard protocol). GROUP 2: Insertion of a balloon cervical catheter (study group). The randomization process will be as follows: A. The eligible patient will sign the informed consent prior to randomization. B. The patient will receive a subject number for the study (from 1 to 200) The study coordinator will open a sealed envelope with the patient's study number to reveal the patient's assigned study group.
Eligibility
Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
Yes
Inclusion criteria
Only patients who meet the following criteria will be approached. 1. Singleton Pregnancy 2. Previous single cesarean section 3. At least 12 months have elapsed since the previous caesarean delivery 4. Diagnosed with confirmed PROM at ≥ 34 weeks' gestation. 5. Ruptured membranes have occurred ≤24 hours prior to inclusion in the study. 6. Vertex presentation well applied to the cervix 7. Found to have an unripe cervix in a speculum examination (Bishop score ≤6). 8. Absence of significant and regular uterine contraction (\<3/10Min). 9. Willingness to comply with the protocol for the duration of the study. 10. Have signed an informed consent (including a TOLAC consent form).
Exclusion criteria
Patients having any of the following conditions will be excluded from the study: 1. Any contraindication for a vaginal delivery (i.e. placenta previa, non-vertex presentation, previous cesarean delivery \< 12 months). 2. Regular uterine contractions (\>3/10Min). 3. Diagnosis of ruptured membranes was made over 24 hours prior to study inclusion. 4. Meconium stained amniotic fluid. 5. Evidence of chorio-amnionitis (T 37.6°C with uterine tenderness and maternal or fetal tachycardia or purulent discharge or WBC20.000) 6. Suspected placental abruption or a significant hemorrhage. 7. Non-reassuring fetal status (as determined by fetal heart rate monitoring and/or bio-physical profile) necessitating immediate intervention.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Vaginal birth after cesarean (VBAC) rates | 5 days |
Secondary
| Measure | Time frame |
|---|---|
| PROM to delivery interval (time) | 5 days |
| intrapartum and post-partum infection rates | 5 days |
| Cesarean section rates | 5 days |
Countries
Israel
Contacts
Primary ContactGil Gutvirtz, MD
Outcome results
None listed